Literature DB >> 12624784

Extraneural metastases of paediatric brain tumours.

Christian H Rickert1.   

Abstract

A survey of published cases of extraneural metastases of primary brain tumours in children under the age of 18 years revealed 245 cases; 60.7% occurred in boys and 27.3% were directly related to the placing of a shunt. The most common entities leading to extraneural metastases were medulloblastomas (56.3%), germinomas (9.8%), glioblastomas (6.9%), ependymomas (3.7%) and pilocytic astrocytomas (2.9%). While medulloblastomas were frequent among non-shunt-related metastases (69.4%), germ cell tumours were most common among shunt-related metastases (33.3%). Metastases were encountered equally often in bone (56.3%) and visceral organs (55.5%) but were markedly rarer in lymph nodes (25.3%). Medulloblastomas showed a preference for bones (88.3% of cases), germinomas for bones (77.8%) and visceral organs (66.7%), whereas ependymomas and ependymoblastomas were more frequently found in lymph nodes and visceral organs (71.5-100%). The most frequent sites of bone metastases were the pelvis (59.3% of cases with osseous lesions), femur (54%) and vertebrae (46%). Medulloblastomas preferentially spread into pelvis, femur and vertebrae, whereas germ cell tumours mainly involved pelvis, femur and ribs and glioblastomas vertebrae and pelvis. Most frequent sites of lymph node metastases were cervical (45.8% of cases with nodular lesions) and thoracic (31.3%) with 54% of children suffering from medulloblastomas and 7.9% from germ cell tumours. The most frequent organ involved in non-shunt-related metastases were the lungs (56.5% of children with visceral lesions) followed by muscle/soft tissue (26.9%), pleura (16.4%), skin (14.9%) and liver (13.4%). Among shunt-related cases, the peritoneum was the most frequent site (86.6% of children). The mean interval between primary brain tumour and occurrence of metastasis was 22.1 months with particularly grave outcomes among medulloblastomas, non-germinomatous germ cell tumours and glioblastomas (85.5-100% deceased children), whereas 60% of children suffering from germinomas were still alive at the time of reporting.

Entities:  

Mesh:

Year:  2003        PMID: 12624784     DOI: 10.1007/s00401-002-0666-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

Review 1.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

2.  Clear cell ependymoma with trisomy 19 developing bone metastases.

Authors:  M Payet; C Conter; F Labrousse; A Maues De Paula; A Marabelle; D Figarella Branger; R Bouvier; D Frappaz
Journal:  Childs Nerv Syst       Date:  2011-12-30       Impact factor: 1.475

3.  Malignant ascites after subduroperitoneal shunt in a patient with leptomeningeal metastasis.

Authors:  Min Ho Lee; Jung-Il Lee
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

4.  A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.

Authors:  Till Milde; Susanne Kleber; Andrey Korshunov; Hendrik Witt; Thomas Hielscher; Philipp Koch; Hans-Georg Kopp; Manfred Jugold; Hedwig E Deubzer; Ina Oehme; Marco Lodrini; Hermann-Josef Gröne; Axel Benner; Oliver Brüstle; Richard J Gilbertson; Andreas von Deimling; Andreas E Kulozik; Stefan M Pfister; Ana Martin-Villalba; Olaf Witt
Journal:  Acta Neuropathol       Date:  2011-08-24       Impact factor: 17.088

Review 5.  A survey of metastatic central nervous system tumors to cervical lymph nodes.

Authors:  Vanni Mondin; Alfio Ferlito; Kenneth O Devaney; Julia A Woolgar; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-08       Impact factor: 2.503

6.  Case - Intra-abdominal metastases following ventriculoperitoneal shunt insertion for primary intracranial germ cell tumor.

Authors:  Kristen McAlpine; Roderick Clark; Maria Jiang; Aaron Hansen; Otto Hemminki; Robert J Hamilton
Journal:  Can Urol Assoc J       Date:  2022-09       Impact factor: 2.052

Review 7.  Diffuse intrinsic pontine glioma ventricular peritoneal shunt metastasis: a case report and literature review.

Authors:  Chloé Louise Gelder; Cynthia Hawkins; Michal Zapotocky; Peter Dirks; Ute Bartels; Eric Bouffet
Journal:  Childs Nerv Syst       Date:  2019-01-31       Impact factor: 1.475

8.  Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression.

Authors:  A K M Ghulam Muhammad; Marianela Candolfi; Gwendalyn D King; Kader Yagiz; David Foulad; Yohei Mineharu; Kurt M Kroeger; Katherine A Treuer; W Stephen Nichols; Nicholas S Sanderson; Jieping Yang; Maksim Khayznikov; Nico Van Rooijen; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

9.  Role of ventriculoperitoneal shunting in patients with neoplasms of the central nervous system: An analysis of 59 cases.

Authors:  Fares Nigim; Jonathan F Critchlow; Ekkehard M Kasper
Journal:  Mol Clin Oncol       Date:  2015-08-31

10.  Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.

Authors:  Niyanta N Kumar; Jeffrey J Lochhead; Michelle E Pizzo; Geetika Nehra; Sam Boroumand; Gretchen Greene; Robert G Thorne
Journal:  J Control Release       Date:  2018-08-04       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.